We are live on ! Find out more
WST icon

West Pharmaceutical
WST

205 hedge funds and large institutions have $2.55B invested in West Pharmaceutical in 2013 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 75 increasing their positions, 84 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

17% more capital invested

Capital invested by funds: $2.19B → $2.55B (+$364M)

4% more funds holding

Funds holding: 197 → 205 (+8)

2.43% less ownership

Funds ownership: 180.46% → 178.02% (-2.4%)

11% less repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 84

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
205
Holders Change
+8
Holders Change %
+4.06%
% of All Funds
6.65%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.19%
New
23
Increased
75
Reduced
84
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BAMCO Inc
BAMCO Inc
New York
+$32.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$29.7M
3
RIM
RS Investment Management
California
+$23.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$16.2M
5
BFA
BlackRock Fund Advisors
California
+$16M

Top Sellers

Rank Fund Capital Flow
1
HIM
Hermes Investment Management
United Kingdom
-$28.5M
2
CIP
Champlain Investment Partners
Vermont
-$27.8M
3
Northern Trust
Northern Trust
Illinois
-$17.5M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$16.9M
5
DIA
Denver Investment Advisors
Colorado
-$15.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
51
Century Capital Management
Massachusetts
$7.88M -$2.97M -77,806 -29%
NFA
52
Nationwide Fund Advisors
Ohio
$7.42M +$1.71M +44,694 +33%
NTCOC
53
Northern Trust Company of Connecticut
Connecticut
$7.3M -$1.95M -51,086 -22%
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$6.97M +$1.85M +48,578 +40%
Public Sector Pension Investment Board (PSP Investments)
55
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$6.91M +$1.44M +37,800 +29%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$6.74M +$107K +2,800 +2%
AllianceBernstein
57
AllianceBernstein
Tennessee
$6.14M -$431K -11,300 -7%
Goldman Sachs
58
Goldman Sachs
New York
$5.88M +$1.31M +34,421 +32%
IMIM
59
Irving Magee Investment Management
Pennsylvania
$5.69M – – –
California Public Employees Retirement System
60
California Public Employees Retirement System
California
$5.46M +$1.01M +26,400 +25%
Deutsche Bank
61
Deutsche Bank
Germany
$5.34M +$1.59M +41,658 +47%
USAA
62
United Services Automobile Association
Texas
$5.17M +$443K +11,600 +10%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$5.12M +$146K +3,824 +3%
BG
64
BlackRock Group
United Kingdom
$5.01M +$1.43M +37,590 +45%
HIM
65
Hermes Investment Management
United Kingdom
$5M -$28.5M -747,194 -86%
WFM
66
Wilmington Funds Management
Delaware
$4.86M +$1.14M +29,940 +34%
Two Sigma Advisers
67
Two Sigma Advisers
New York
$4.54M +$790K +20,700 +23%
Public Employees Retirement Association of Colorado
68
Public Employees Retirement Association of Colorado
Colorado
$4.5M +$91.6K +2,400 +2%
PPA
69
Parametric Portfolio Associates
Washington
$4.39M +$116K +3,031 +3%
KTC
70
Kistler-Tiffany Companies
Pennsylvania
$4.39M – – –
Morgan Stanley
71
Morgan Stanley
New York
$4.32M -$332K -8,708 -8%
WT
72
Wilmington Trust
Delaware
$4.3M -$98.1K -2,572 -2%
Comerica Bank
73
Comerica Bank
Texas
$4.12M +$3.82M +100,108 New
TA
74
Teachers Advisors
New York
$3.88M +$109K +2,864 +3%
QBFM
75
QS Batterymarch Financial Management
New York
$3.73M – – –
1 2
3
4 5

WST Hedge Fund Activity: Q3 2013 in Review

205 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2013, worth a combined $2.55B — up 17% from $2.19B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new WST positions and 13 closed out — a net gain of 10 holders — while 75 added to existing stakes and 84 trimmed.

The largest buyer was BAMCO Inc, adding an estimated $32.7M. The largest seller was Hermes Investment Management, cutting an estimated $28.5M.

  • 205 institutional investors held West Pharmaceutical (WST) as of Q3 2013, up from 197 in Q2 2013.
  • Funds reported $2.55B of West Pharmaceutical stock for Q3 2013, up 17% quarter-over-quarter.
  • 23 funds opened new West Pharmaceutical positions in Q3 2013 and 13 closed out, a net change of +10 holders.
  • The largest West Pharmaceutical buyer in Q3 2013 was BAMCO Inc, an estimated $32.7M added.
  • The largest West Pharmaceutical seller in Q3 2013 was Hermes Investment Management, an estimated $28.5M sold.

Based on aggregated 13F filings for Q3 2013.